Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA

Br J Haematol. 2019 May;185(4):764-767. doi: 10.1111/bjh.15606. Epub 2018 Oct 18.

Authors

Affiliations

¹ Haemophilia Centre, University Hospital, Nantes, France.
² Haemophilia Centre, University Hospital, Rennes, France.
³ Haemophilia Centre, University Hospital, Angers, France.
⁴ Haemophilia Centre, University Hospital, Brest, France.
⁵ Haemophilia Centre, University Hospital, Tours, France.
⁶ Haemophilia Centre, Hospital Le Mans, Le Mans, France.
⁷ Haemophilia Centre, University Hospital, Lyon, France.

PMID: 30338508
DOI: 10.1111/bjh.15606

No abstract available

Keywords: anticoagulation; cardiology; haemophilia.

Publication types

Clinical Trial
Comparative Study
Letter
Multicenter Study

MeSH terms

Aged
Aged, 80 and over
Cardiovascular Diseases / drug therapy*
Case-Control Studies
Factor IX / metabolism
Factor VIII / metabolism
Fibrinolytic Agents / adverse effects*
Hemophilia A / complications*
Hemorrhage / chemically induced*
Humans
Middle Aged
Risk Factors

Substances

Fibrinolytic Agents
Factor VIII
Factor IX

Associated data

ClinicalTrials.gov/NCT03157154